Gentherm

THRM

Market cap $1.15B

Gentherm Incorporated remains a soft Buy as its transformation and merger with Modine Performance Technologies drive significant upside potential. THRM delivered impressive Q1 FY2026 results: sales up 11.2% to $393.7M, outpacing a contracting vehicle production market. Management guides for FY2026 revenue of $1.5–$1.6B and EBITDA of $175–$195M, with the Modine merger expected to boost combined revenue to $2.6B and EBITDA to $322M.

The market consistently misprices the physical infrastructure required to sustain exponential technological growth. Right now, the structural bottleneck for artificial intelligence (AI) is not silicon availability.

NOVI, Mich., May 26, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM) a global market leader of innovative thermal management and pneumatic comfort technologies, has been presented with a 2025 Supplier of the Year Award at General Motors' 34th annual Supplier of the Year event in Austin, Texas.

NOVI, Mich., May 20, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the following upcoming investor conference in the second quarter of 2026.

NOVI, Mich., May 14, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced it will showcase its latest expansion into the Home and Office market at NeoCon 2026 in Chicago, IL including Preview Day on June 7, 2026 and exhibit days June 8–10, 2026.

It is important to distinguish between capital inflows and short-term price performance, as flow activity and directional momentum do not always align.

Modine Manufacturing led the way during the quarter, benefiting from secular demand in data center cooling and a well received spinoff of Modine Manufacturing's auto cooling business. Coming out of 2025, Adeia reported record revenue and profitability, supported by a surge in IP licensing activity. AtriCure remains well positioned given its first-mover advantage and deep integration within surgical workflows despite near-term competitive concerns from Edwards Lifesciences.

Gentherm Incorporated (THRM) Q1 2026 Earnings Call Transcript

Gentherm (THRM) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.51 per share a year ago.

Gentherm (THRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.